価格表

在庫・価格 : 2025年07月02日 01時49分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Active Mouse Recombinant Alpha Synuclein Pre-formed Fibrils(Type 1)
データシート※最新のデータシートでない場合があります
SPR-324E STQストレスマークバイオサイエンス
StressMarq Biosciences Inc.
5x100 μg ¥339,000
(未発注)
追加

在庫・価格 : 2025年07月02日 01時49分 現在

Active Mouse Recombinant Alpha Synuclein Pre-formed Fibrils(Type 1)

  • 商品コード:SPR-324E
  • メーカー:STQ
  • 包装:5x100μg
  • 価格: ¥339,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Cao B et al. PDCD4 triggers α-synuclein accumulation and motor deficits via co-suppressing TFE3 and TFEB translation in a model of Parkinson's disease. NPJ Parkinsons Dis 2024 Aug;10(1):146
Cao B et al
2024/01/01
PubMed
2 Parmasad JA et al. Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy. Cell Death Dis 2024 Apr;15(4):246
Parmasad JA et al
2024/01/01
PubMed
3 Holland DC et al. &#x3B1;-Synuclein Aggregation Inhibitory Prunolides and a Dibrominated &#x3B2;-Carboline Sulfamate from the Ascidian <i>Synoicum prunum</i>. J Nat Prod 2022 Feb;85(2):441-452
Holland DC et al
2022/01/01
PubMed
4 Desai AA et al. Flow cytometric isolation of drug-like conformational antibodies specific for amyloid fibrils. bioRxiv 2023 Jul;
Desai AA et al
2023/01/01
PubMed
5 Lee J et al. Targeted degradation of &#x237A;-synuclein aggregates in Parkinson&#39;s disease using the AUTOTAC technology. Mol Neurodegener 2023 Jun;18(1):41
Lee J et al
2023/01/01
PubMed
6 Ghosh AA et al. A Novel NOX Inhibitor Treatment Attenuates Parkinson&#39;s Disease-Related Pathology in Mouse Models. Int J Mol Sci 2022 Apr;23(8)
Ghosh AA et al
2022/01/01
PubMed
7 Hlushchuk I et al. Cell Culture Media, Unlike the Presence of Insulin, Affect &#x3B1;-Synuclein Aggregation in Dopaminergic Neurons. Biomolecules 2022 04;12(4)
Hlushchuk I et al
2022/01/01
PubMed
8 Verma DK et al. Alpha-Synuclein Preformed Fibrils Induce Cellular Senescence in Parkinson&#39;s Disease Models. Cells 2021 07;10(7)
Verma DK et al
2021/01/01
PubMed
9 Bhatia TN et al. Heat Shock Protein 70 as a Sex-Skewed Regulator of &#x3B1;-Synucleinopathy. Neurotherapeutics 2021 10;18(4):2541-2564
Bhatia TN et al
2021/01/01
PubMed
10 Hlushchuk I et al. Domain-Independent Inhibition of CBP/p300 Attenuates &#x3B1;-Synuclein Aggregation. ACS Chem Neurosci 2021 07;12(13):2273-2279
Hlushchuk I et al
2021/01/01
PubMed
11 Verma DK et al. The SUMO Conjugase Ubc9 Protects Dopaminergic Cells from Cytotoxicity and Enhances the Stability of &#x3B1;-Synuclein in Parkinson&#39;s Disease Models. eNeuro ;7(5)
Verma DK et al
PubMed
  • No.: 1
  • 文献情報:
    Cao B et al. PDCD4 triggers &#x3B1;-synuclein accumulation and motor deficits via co-suppressing TFE3 and TFEB translation in a model of Parkinson&#39;s disease. NPJ Parkinsons Dis 2024 Aug;10(1):146
    Cao B et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Parmasad JA et al. Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy. Cell Death Dis 2024 Apr;15(4):246
    Parmasad JA et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Holland DC et al. &#x3B1;-Synuclein Aggregation Inhibitory Prunolides and a Dibrominated &#x3B2;-Carboline Sulfamate from the Ascidian <i>Synoicum prunum</i>. J Nat Prod 2022 Feb;85(2):441-452
    Holland DC et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Desai AA et al. Flow cytometric isolation of drug-like conformational antibodies specific for amyloid fibrils. bioRxiv 2023 Jul;
    Desai AA et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Lee J et al. Targeted degradation of &#x237A;-synuclein aggregates in Parkinson&#39;s disease using the AUTOTAC technology. Mol Neurodegener 2023 Jun;18(1):41
    Lee J et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Ghosh AA et al. A Novel NOX Inhibitor Treatment Attenuates Parkinson&#39;s Disease-Related Pathology in Mouse Models. Int J Mol Sci 2022 Apr;23(8)
    Ghosh AA et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Hlushchuk I et al. Cell Culture Media, Unlike the Presence of Insulin, Affect &#x3B1;-Synuclein Aggregation in Dopaminergic Neurons. Biomolecules 2022 04;12(4)
    Hlushchuk I et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Verma DK et al. Alpha-Synuclein Preformed Fibrils Induce Cellular Senescence in Parkinson&#39;s Disease Models. Cells 2021 07;10(7)
    Verma DK et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Bhatia TN et al. Heat Shock Protein 70 as a Sex-Skewed Regulator of &#x3B1;-Synucleinopathy. Neurotherapeutics 2021 10;18(4):2541-2564
    Bhatia TN et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Hlushchuk I et al. Domain-Independent Inhibition of CBP/p300 Attenuates &#x3B1;-Synuclein Aggregation. ACS Chem Neurosci 2021 07;12(13):2273-2279
    Hlushchuk I et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Verma DK et al. The SUMO Conjugase Ubc9 Protects Dopaminergic Cells from Cytotoxicity and Enhances the Stability of &#x3B1;-Synuclein in Parkinson&#39;s Disease Models. eNeuro ;7(5)
    Verma DK et al
  • 備考:
  • 参照:
    PubMed